Goldman, J. W., Yang, X., Hochmair, M., Wu, L., Kim, H. R., Paz-Ares, L. G., Rieke, D. T., Johnson, M. L., Yang, J. C. H., Tsuboi, M., Besse, B., Sharma, N., Maeda, P. H., Peterson, P., Frimodt-Moller, B., Yang, Y., Drilon, A. E., Wu, Y. (2026). Event-free survival with adjuvant selpercatinib in stage IB-IIIA
                    <i>RET</i>
                    fusion-positive NSCLC: Primary results of the phase 3 LIBRETTO-432 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba3